Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia

• Mehmet Sezgin Pepeler,
• Simten Dağdaş,
• Emel İşleyen,
• Gaye Kalacı Katayıfçı,
• Aydan Kılıçarslan,
• Esra Özhamam,
• Muhammed Talha Adakul,
• Fahir Öztürk,
• Funda Ceran,
• Gülsüm Özet

Affiliations

Mehmet Sezgin Pepeler

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Simten Dağdaş

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Emel İşleyen

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Gaye Kalacı Katayıfçı

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Aydan Kılıçarslan

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Esra Özhamam

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Muhammed Talha Adakul

ORCiD

Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye

Fahir Öztürk

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Funda Ceran

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Gülsüm Özet

ORCiD

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye